CSIMarket Company Name, Ticker, Industry, else..
 
Akumin Inc   (AKU)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 
Price: $0.2887 $-0.06 -17.866%
Day's High: $0.35 Week Perf: 98.83 %
Day's Low: $ 0.28 30 Day Perf: 93.76 %
Volume (M): 8,543 52 Wk High: $ 0.50
Volume (M$): $ 2,466 52 Wk Avg: $0.20
Open: $0.32 52 Wk Low: $0.13



 Market Capitalization (Millions $) 26
 Shares Outstanding (Millions) 92
 Employees -
 Revenues (TTM) (Millions $) 738
 Net Income (TTM) (Millions $) -258
 Cash Flow (TTM) (Millions $) -28
 Capital Exp. (TTM) (Millions $) 31

Akumin Inc
Akumin Inc is a leading provider of outpatient diagnostic imaging services in the United States. The company operates a network of imaging centers that offer a wide range of services, including MRI, CT scan, ultrasound, X-ray, and PET/CT scans. Akumin is known for its state-of-the-art facilities, advanced imaging technology, and dedicated team of radiologists and technologists. The company aims to provide high-quality, compassionate care to its patients, with a focus on accuracy, efficiency, and convenience. Akumin serves a broad range of patients, including those referred by physicians, hospitals, and other healthcare providers.


   Company Address: 8300 W. Sunrise Boulevard Plantation 33322 FL
   Company Phone Number: 730-0050   Stock Exchange / Ticker: AKU


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Akumin Inc

Akumin Inc Faces 3.205% Revenue Slide, Raising Concerns Over Financial Health



In the fiscal interval closing September 30, 2023, Akumin Inc, a leading provider of diagnostic imaging services, faced a challenging period marked by diminishing returns. The company reported a decrease in revenue of -3.205% to $180.62 million, which is down from $184.84 million in the prior reporting period. This downward trend in revenue resulted in a net shortfall of $-83.495 million, a significant increase compared to $-49.745 million reported a year ago.
Revenue Decline:
Akumin's declining revenue indicates potential concerns for the company's financial health. The -3.205% contraction in revenue suggests a slowdown in business operations for the diagnostic imaging services provider. Compared to the preceding year, the company suffered a -2.281% decline in revenue, which accentuates a worrisome trend for Akumin.
Earnings Per Share:
The impact of lower revenue also affected Akumin's earnings per share (EPS). The company's EPS shortfall per share increased to $-0.90, up from $-0.60 realized in the corresponding period a year ago. This decline in EPS further underscores the challenges faced by Akumin in maintaining profitability.
Akumin Inc

Akumin Inc's Revenue Plunges by $29 Million Despite Expectations, Sending Shockwaves through Investors

Akumin Inc, a medical laboratories company, recently released its financial results for the fiscal year ending March 31, 2023. Despite generating a revenue of $187.592 million, the company incurred a net deficit of $-29.190 million, a decline from the previous year's balanced books. This comes as a shock to investors who expected the company to perform better due to its previous track record.
Akumin Inc's financial statement is a cause for concern as the company's financial health is going downhill. The significant dip in profits is enough to send investors running away. The medical laboratory industry is highly competitive, and with such a disappointing performance, Akumin is losing steam in comparison to its competitors.






Akumin Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com